Sotera Health Shares Rise 18% in a Year. Here's What a $37 Million Stake Trim Signals

1 day ago 4

Jonathan Ponciano, The Motley Fool

Sun, March 15, 2026 astatine 9:50 AM CDT 4 min read

On February 17, 2026, MIG Capital disclosed a simplification successful its holdings of Sotera Health (NASDAQ:SHC), selling 2,262,292 shares. The estimated transaction value, based connected quarterly mean pricing, is $37.41 million.

According to an SEC filing dated February 17, 2026, MIG Capital reduced its involvement successful Sotera Health by 2,262,292 shares during the 4th fourth of 2025. The estimated worth of the sold shares is $37.41 million, based connected the mean closing terms for the quarter. At quarter’s end, the full presumption worth declined by $31.83 million, a fig that includes some trading and stock terms changes.

This was a merchantability transaction, leaving Sotera Health astatine 5.88% of MIG Capital’s 13F assets nether management.
Top holdings aft the filing:
- NASDAQ:META: $52.45 cardinal (8.9% of AUM)
- NASDAQ:DXCM: $40.19 cardinal (6.8% of AUM)
- NASDAQ:SHC: $34.65 cardinal (5.9% of AUM)
- NASDAQ:MSFT: $34.25 cardinal (5.8% of AUM)
- NASDAQ:CELH: $33.93 cardinal (5.8% of AUM)
As of Friday, Sotera Health shares were priced astatine $13.41, up 18% implicit the past year, which was conscionable somewhat nether the S&P 500’s astir 20% summation successful the aforesaid period.

Metric

Value

Price (as of Friday)	$13.41
Market capitalization	$3.8 billion
Revenue (TTM)	$1.16 billion
Net income (TTM)	$77.95 million

Sotera Health provides sterilization services (gamma, electron beam, EO processing), laboratory testing, and advisory solutions for aesculapian device, pharmaceutical, and nutrient industries.
The steadfast operates a service-based concern exemplary generating gross done sterilization, laboratory testing, and consulting for regulated industries.
It serves aesculapian instrumentality manufacturers, pharmaceutical companies, and food/agricultural producers crossed North America, Europe, and globally.

Sotera Health is simply a starring supplier of sterilization and laboratory services, supporting captious proviso chains successful healthcare, pharmaceuticals, and nutrient safety. The institution leverages a diversified portfolio of sterilization technologies and investigating capabilities to service highly regulated industries. Its scale, method expertise, and planetary scope supply a competitory vantage successful ensuring information and compliance for its customers.

Sotera continues to standard portion maintaining beardown profitability, and it conscionable posted its 20th consecutive twelvemonth of gross growth. In 2025, income climbed 5.7% to $1.16 billion, portion adjusted EBITDA roseate 8.2% to astir $594 million, reflecting coagulated operating leverage crossed its Sterigenics sterilization concern and related investigating services. Meanwhile, nett income astir doubled from the anterior twelvemonth to $78 million, showing meaningful advancement connected the bottommost line.

Despite trimming its position, the holding inactive represents astir 6% of portfolio assets, placing it among the fund’s larger positions alongside companies similar Meta, DexCom, and Microsoft. That suggests this determination could conscionable beryllium regular portfolio absorption alternatively than reflecting a melodramatic displacement successful conviction. It’s besides important to enactment that shares person fallen astir 24% this year, and the one-year summation beforehand was importantly larger. With that successful mind, MIG whitethorn person conscionable been locking successful gains.

So what does that mean for investors watching Sotera? Ultimately, the institution expects different twelvemonth of growth, projecting revenues to summation betwixt 5% and 6.5% successful 2026, and adjusted EBITDA to turn betwixt 5.5% and 7%. If it delivers, it makes consciousness wherefore a money similar MIG would proceed to clasp a meaningful position.

Read Entire Article